Thailand

Thailand

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
4.75 (4.43 - 5.09) 2019 Modelled IHME
4.86 (4.54 - 5.17) 2018 Modelled IHME
4.93 (4.58 - 5.29) 2017 Modelled IHME
4.97 (4.63 - 5.28) 2016 Modelled IHME
4.99 (4.63 - 5.35) 2015 Modelled IHME
5.04 (4.69 - 5.38) 2014 Modelled IHME
5.1 (4.77 - 5.43) 2013 Modelled IHME
5.16 (4.84 - 5.51) 2012 Modelled IHME
5.23 (4.89 - 5.57) 2011 Modelled IHME
5.29 (4.93 - 5.65) 2010 Modelled IHME
5.34 (4.99 - 5.68) 2009 Modelled IHME
5.39 (5.05 - 5.73) 2008 Modelled IHME
5.44 (5.11 - 5.77) 2007 Modelled IHME
5.49 (5.13 - 5.84) 2006 Modelled IHME
5.55 (5.17 - 5.92) 2005 Modelled IHME
5.61 (5.23 - 5.99) 2004 Modelled IHME
5.68 (5.29 - 6.06) 2003 Modelled IHME
5.75 (5.35 - 6.13) 2002 Modelled IHME
5.83 (5.41 - 6.23) 2001 Modelled IHME
5.91 (5.47 - 6.35) 2000 Modelled IHME
6 (5.60 - 6.46) 1999 Modelled IHME
6.1 (5.70 - 6.57) 1998 Modelled IHME
6.2 (5.80 - 6.70) 1997 Modelled IHME
6.31 (5.89 - 6.84) 1996 Modelled IHME
6.4 (5.95 - 6.98) 1995 Modelled IHME
6.49 (6.04 - 7.09) 1994 Modelled IHME
6.58 (6.13 - 7.20) 1993 Modelled IHME
6.67 (6.18 - 7.31) 1992 Modelled IHME
6.75 (6.24 - 7.42) 1991 Modelled IHME
6.84 (6.28 - 7.51) 1990 Modelled IHME
0.7 2006 Survey/reported Chongsrisawat V et al, 2006
1.36 (0.98 - 1.79) 2015 Modelled WHO
3.5 (1.60 - 4) 2016 Modelled Razavi-Shearer et al, 2018
6.42 (6.37 - 6.47) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.36 (0.28 - 0.45) 2019 Modelled IHME
0.38 (0.30 - 0.47) 2018 Modelled IHME
0.39 (0.30 - 0.49) 2017 Modelled IHME
0.39 (0.31 - 0.49) 2016 Modelled IHME
0.4 (0.31 - 0.50) 2015 Modelled IHME
0.41 (0.32 - 0.51) 2014 Modelled IHME
0.44 (0.35 - 0.54) 2013 Modelled IHME
0.47 (0.37 - 0.58) 2012 Modelled IHME
0.49 (0.39 - 0.60) 2011 Modelled IHME
0.5 (0.39 - 0.61) 2010 Modelled IHME
0.49 (0.39 - 0.60) 2009 Modelled IHME
0.46 (0.37 - 0.57) 2008 Modelled IHME
0.44 (0.34 - 0.54) 2007 Modelled IHME
0.41 (0.32 - 0.51) 2006 Modelled IHME
0.4 (0.31 - 0.50) 2005 Modelled IHME
0.4 (0.31 - 0.50) 2004 Modelled IHME
0.4 (0.32 - 0.50) 2003 Modelled IHME
0.41 (0.32 - 0.51) 2002 Modelled IHME
0.41 (0.32 - 0.52) 2001 Modelled IHME
0.41 (0.32 - 0.54) 2000 Modelled IHME
0.44 (0.34 - 0.57) 1999 Modelled IHME
0.5 (0.39 - 0.64) 1998 Modelled IHME
0.59 (0.46 - 0.74) 1997 Modelled IHME
0.71 (0.56 - 0.87) 1996 Modelled IHME
0.84 (0.66 - 1.04) 1995 Modelled IHME
1.06 (0.84 - 1.31) 1994 Modelled IHME
1.42 (1.12 - 1.75) 1993 Modelled IHME
1.89 (1.50 - 2.33) 1992 Modelled IHME
2.44 (1.94 - 3.03) 1991 Modelled IHME
3.04 (2.41 - 3.81) 1990 Modelled IHME
0.17 (0.10 - 0.26) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
3,887,930 (3,570,760 - 4,273,890) 1990 Modelled IHME
3,893,880 (3,598,450 - 4,276,700) 1991 Modelled IHME
3,894,310 (3,609,680 - 4,267,570) 1992 Modelled IHME
3,888,050 (3,618,350 - 4,255,780) 1993 Modelled IHME
3,875,970 (3,607,960 - 4,232,890) 1994 Modelled IHME
3,860,020 (3,587,190 - 4,209,490) 1995 Modelled IHME
3,837,470 (3,585,110 - 4,164,920) 1996 Modelled IHME
3,807,190 (3,561,330 - 4,113,900) 1997 Modelled IHME
3,772,980 (3,527,060 - 4,063,790) 1998 Modelled IHME
3,738,630 (3,486,220 - 4,019,890) 1999 Modelled IHME
3,708,610 (3,430,760 - 3,981,820) 2000 Modelled IHME
3,683,580 (3,418,170 - 3,935,960) 2001 Modelled IHME
3,660,320 (3,405,100 - 3,896,330) 2002 Modelled IHME
3,639,180 (3,391,630 - 3,879,690) 2003 Modelled IHME
3,620,640 (3,374,180 - 3,864,080) 2004 Modelled IHME
3,604,570 (3,356,830 - 3,847,270) 2005 Modelled IHME
3,640,340 (3,399,150 - 3,871,280) 2006 Modelled IHME
3,726,650 (3,496,870 - 3,954,010) 2007 Modelled IHME
3,726,270 (3,487,830 - 3,962,180) 2008 Modelled IHME
3,634,070 (3,396,890 - 3,862,950) 2009 Modelled IHME
3,580,170 (3,335,350 - 3,821,900) 2010 Modelled IHME
3,560,660 (3,329,580 - 3,795,040) 2011 Modelled IHME
3,536,930 (3,314,610 - 3,773,210) 2012 Modelled IHME
3,509,910 (3,280,980 - 3,737,570) 2013 Modelled IHME
3,484,020 (3,242,300 - 3,716,430) 2014 Modelled IHME
3,465,860 (3,212,140 - 3,709,160) 2015 Modelled IHME
3,457,800 (3,221,120 - 3,676,520) 2016 Modelled IHME
3,444,550 (3,195,480 - 3,691,590) 2017 Modelled IHME
3,402,530 (3,178,890 - 3,620,480) 2018 Modelled IHME
3,333,110 (3,103,550 - 3,569,810) 2019 Modelled IHME
2,412,000 (1,126,000 - 2,784,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
18.9 (13.20 - 26.10) 2019 Modelled IHME
18.5 (13.40 - 25.20) 2018 Modelled IHME
18.2 (13.50 - 23.70) 2017 Modelled IHME
17.8 (14.10 - 22.40) 2016 Modelled IHME
17.2 (13.80 - 21.20) 2015 Modelled IHME
17 (13.50 - 20.80) 2014 Modelled IHME
16.7 (13.50 - 20.40) 2013 Modelled IHME
16.7 (13.50 - 20.60) 2012 Modelled IHME
16.4 (13.20 - 20.10) 2011 Modelled IHME
15.9 (12.60 - 19.50) 2010 Modelled IHME
15.2 (12.20 - 18.50) 2009 Modelled IHME
14.6 (11.80 - 17.70) 2008 Modelled IHME
14.3 (11.60 - 17.50) 2007 Modelled IHME
14.3 (11.50 - 17.50) 2006 Modelled IHME
14.1 (11.30 - 17.20) 2005 Modelled IHME
13.9 (11.10 - 16.70) 2004 Modelled IHME
13.8 (11.30 - 16.60) 2003 Modelled IHME
13.8 (11.30 - 16.60) 2002 Modelled IHME
13.6 (10.80 - 16.90) 2001 Modelled IHME
14.2 (11.50 - 17.20) 2000 Modelled IHME
14.2 (11.40 - 17.20) 1999 Modelled IHME
13.4 (10.30 - 16.80) 1998 Modelled IHME
13.2 (10.40 - 16.40) 1997 Modelled IHME
14.1 (11.60 - 16.90) 1996 Modelled IHME
13.9 (11.50 - 16.60) 1995 Modelled IHME
13.6 (11.40 - 16) 1994 Modelled IHME
13.3 (11.20 - 15.90) 1993 Modelled IHME
13 (10.90 - 15.40) 1992 Modelled IHME
12.7 (10.70 - 15) 1991 Modelled IHME
12.3 (10.30 - 14.50) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
13,240 (9,240 - 18,333) 2019 Modelled IHME
12,977 (9,360 - 17,643) 2018 Modelled IHME
12,736 (9,430 - 16,524) 2017 Modelled IHME
12,414 (9,814 - 15,605) 2016 Modelled IHME
11,962 (9,589 - 14,720) 2015 Modelled IHME
11,741 (9,364 - 14,384) 2014 Modelled IHME
11,520 (9,259 - 14,072) 2013 Modelled IHME
11,422 (9,218 - 14,105) 2012 Modelled IHME
11,152 (8,977 - 13,666) 2011 Modelled IHME
10,769 (8,546 - 13,170) 2010 Modelled IHME
10,309 (8,317 - 12,563) 2009 Modelled IHME
10,057 (8,133 - 12,222) 2008 Modelled IHME
9,803 (7,914 - 11,959) 2007 Modelled IHME
9,497 (7,638 - 11,611) 2006 Modelled IHME
9,147 (7,312 - 11,187) 2005 Modelled IHME
8,945 (7,189 - 10,795) 2004 Modelled IHME
8,834 (7,257 - 10,620) 2003 Modelled IHME
8,747 (7,176 - 10,539) 2002 Modelled IHME
8,584 (6,820 - 10,658) 2001 Modelled IHME
8,881 (7,241 - 10,804) 2000 Modelled IHME
8,831 (7,127 - 10,685) 1999 Modelled IHME
8,309 (6,377 - 10,395) 1998 Modelled IHME
8,125 (6,358 - 10,086) 1997 Modelled IHME
8,583 (7,031 - 10,306) 1996 Modelled IHME
8,375 (6,924 - 9,988) 1995 Modelled IHME
8,115 (6,829 - 9,571) 1994 Modelled IHME
7,844 (6,609 - 9,365) 1993 Modelled IHME
7,605 (6,384 - 8,980) 1992 Modelled IHME
7,331 (6,186 - 8,641) 1991 Modelled IHME
6,983 (5,863 - 8,241) 1990 Modelled IHME
16,512 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
40 (31 - 49) 2019 Modelled IHME
40 (31 - 50) 2018 Modelled IHME
40 (32 - 50) 2017 Modelled IHME
41 (32 - 50) 2016 Modelled IHME
41 (32 - 50) 2015 Modelled IHME
41 (33 - 51) 2014 Modelled IHME
41 (33 - 51) 2013 Modelled IHME
42 (33 - 51) 2012 Modelled IHME
42 (34 - 52) 2011 Modelled IHME
42 (34 - 52) 2010 Modelled IHME
43 (34 - 52) 2009 Modelled IHME
43 (35 - 52) 2008 Modelled IHME
44 (35 - 53) 2007 Modelled IHME
44 (36 - 53) 2006 Modelled IHME
44 (36 - 53) 2005 Modelled IHME
45 (37 - 54) 2004 Modelled IHME
46 (38 - 55) 2003 Modelled IHME
47 (38 - 55) 2002 Modelled IHME
47 (39 - 56) 2001 Modelled IHME
48 (39 - 57) 2000 Modelled IHME
48 (40 - 57) 1999 Modelled IHME
49 (40 - 58) 1998 Modelled IHME
49 (41 - 58) 1997 Modelled IHME
49 (41 - 59) 1996 Modelled IHME
50 (41 - 59) 1995 Modelled IHME
50 (41 - 59) 1994 Modelled IHME
50 (41 - 58) 1993 Modelled IHME
49 (41 - 58) 1992 Modelled IHME
49 (41 - 58) 1991 Modelled IHME
49 (41 - 58) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
98 2012 Survey/reported WHO/UNICEF
98 2011 Survey/reported WHO/UNICEF
98 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
98 2008 Survey/reported WHO/UNICEF
96 2007 Survey/reported WHO/UNICEF
96 2006 Survey/reported WHO/UNICEF
96 2005 Survey/reported WHO/UNICEF
96 2004 Survey/reported WHO/UNICEF
96 2003 Survey/reported WHO/UNICEF
95 2002 Survey/reported WHO/UNICEF
95 2001 Survey/reported WHO/UNICEF
95 2000 Survey/reported WHO/UNICEF
95 1999 Survey/reported WHO/UNICEF
95 1998 Survey/reported WHO/UNICEF
94 1997 Survey/reported WHO/UNICEF
93 1996 Survey/reported WHO/UNICEF
93 1995 Survey/reported WHO/UNICEF
66 1994 Survey/reported WHO/UNICEF
58 1993 Survey/reported WHO/UNICEF
15 1992 Survey/reported WHO/UNICEF
97 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
24 2017 Survey/reported Thailand Ending AIDS, 2015; Aramrattana A, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
21 2016 Survey/reported Larney et al, 2017
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.18 (0.97 - 1.42) 2019 Modelled IHME
1.18 (0.97 - 1.43) 2018 Modelled IHME
1.18 (0.97 - 1.44) 2017 Modelled IHME
1.18 (0.97 - 1.44) 2016 Modelled IHME
1.18 (0.97 - 1.44) 2015 Modelled IHME
1.19 (0.98 - 1.44) 2014 Modelled IHME
1.21 (1 - 1.47) 2013 Modelled IHME
1.24 (1.02 - 1.49) 2012 Modelled IHME
1.26 (1.04 - 1.51) 2011 Modelled IHME
1.27 (1.04 - 1.52) 2010 Modelled IHME
1.25 (1.03 - 1.49) 2009 Modelled IHME
1.21 (1 - 1.44) 2008 Modelled IHME
1.15 (0.96 - 1.36) 2007 Modelled IHME
1.11 (0.92 - 1.31) 2006 Modelled IHME
1.09 (0.91 - 1.29) 2005 Modelled IHME
1.1 (0.92 - 1.31) 2004 Modelled IHME
1.14 (0.96 - 1.35) 2003 Modelled IHME
1.19 (1 - 1.40) 2002 Modelled IHME
1.23 (1.03 - 1.44) 2001 Modelled IHME
1.24 (1.04 - 1.47) 2000 Modelled IHME
1.24 (1.04 - 1.46) 1999 Modelled IHME
1.24 (1.05 - 1.46) 1998 Modelled IHME
1.24 (1.05 - 1.47) 1997 Modelled IHME
1.24 (1.05 - 1.47) 1996 Modelled IHME
1.24 (1.04 - 1.47) 1995 Modelled IHME
1.26 (1.05 - 1.49) 1994 Modelled IHME
1.3 (1.08 - 1.55) 1993 Modelled IHME
1.37 (1.12 - 1.64) 1992 Modelled IHME
1.45 (1.17 - 1.75) 1991 Modelled IHME
1.54 (1.22 - 1.88) 1990 Modelled IHME
0.39 2014 Modelled Wasitthankasem et al, 2016
1 2004 Modelled Wasitthankasem et al, 2016
0.7 (0.40 - 0.70) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.94 2014 Modelled Wasitthankasem et al, 2016
2.15 2004 Modelled Wasitthankasem et al, 2016
2.7 (1.80 - 3.70) 2014 Modelled Gower et al, 2014
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
88.5 (82.60 - 92.90) 2005 Survey/reported Luksamijarulkul P et al, 2009
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
874,249 (691,442 - 1,071,710) 1990 Modelled IHME
835,791 (672,442 - 1,008,130) 1991 Modelled IHME
799,659 (653,949 - 955,338) 1992 Modelled IHME
769,934 (636,349 - 918,080) 1993 Modelled IHME
751,276 (627,580 - 889,775) 1994 Modelled IHME
748,648 (627,692 - 886,942) 1995 Modelled IHME
755,659 (636,014 - 893,224) 1996 Modelled IHME
762,526 (642,830 - 902,472) 1997 Modelled IHME
769,079 (646,551 - 901,834) 1998 Modelled IHME
775,122 (650,351 - 910,632) 1999 Modelled IHME
780,589 (651,925 - 920,504) 2000 Modelled IHME
775,652 (650,321 - 909,392) 2001 Modelled IHME
756,355 (633,730 - 889,968) 2002 Modelled IHME
731,983 (612,925 - 864,525) 2003 Modelled IHME
712,118 (595,203 - 842,409) 2004 Modelled IHME
706,488 (588,889 - 836,051) 2005 Modelled IHME
733,378 (611,594 - 868,163) 2006 Modelled IHME
788,639 (657,591 - 934,301) 2007 Modelled IHME
832,773 (691,806 - 991,872) 2008 Modelled IHME
850,221 (701,529 - 1,014,680) 2009 Modelled IHME
858,682 (705,134 - 1,029,410) 2010 Modelled IHME
857,703 (707,039 - 1,027,000) 2011 Modelled IHME
848,150 (700,742 - 1,020,800) 2012 Modelled IHME
834,745 (687,328 - 1,010,740) 2013 Modelled IHME
823,161 (675,941 - 997,676) 2014 Modelled IHME
819,659 (671,254 - 1,001,740) 2015 Modelled IHME
822,445 (672,266 - 1,000,040) 2016 Modelled IHME
825,094 (674,274 - 1,005,810) 2017 Modelled IHME
827,240 (675,644 - 998,673) 2018 Modelled IHME
829,190 (679,769 - 998,019) 2019 Modelled IHME
463,000 (255,000 - 487,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
13.6 (9.45 - 18.70) 2019 Modelled IHME
13.3 (9.53 - 18.20) 2018 Modelled IHME
13.1 (9.58 - 17.30) 2017 Modelled IHME
12.9 (10 - 16.40) 2016 Modelled IHME
12.5 (9.69 - 15.60) 2015 Modelled IHME
12.2 (9.41 - 15.40) 2014 Modelled IHME
11.9 (9.26 - 14.90) 2013 Modelled IHME
11.7 (9.16 - 14.60) 2012 Modelled IHME
11.4 (8.94 - 14.30) 2011 Modelled IHME
11.1 (8.78 - 14) 2010 Modelled IHME
10.5 (8.31 - 13) 2009 Modelled IHME
10 (7.97 - 12.30) 2008 Modelled IHME
9.7 (7.68 - 11.90) 2007 Modelled IHME
9.58 (7.54 - 11.90) 2006 Modelled IHME
9.3 (7.35 - 11.60) 2005 Modelled IHME
9.04 (7.23 - 11.10) 2004 Modelled IHME
8.74 (6.95 - 10.60) 2003 Modelled IHME
8.4 (6.53 - 10.40) 2002 Modelled IHME
7.99 (6.06 - 10.10) 2001 Modelled IHME
8.06 (6.21 - 10.10) 2000 Modelled IHME
7.86 (6.07 - 9.99) 1999 Modelled IHME
7.3 (5.46 - 9.37) 1998 Modelled IHME
7.12 (5.39 - 9.06) 1997 Modelled IHME
7.48 (5.88 - 9.37) 1996 Modelled IHME
7.33 (5.80 - 9.04) 1995 Modelled IHME
7.19 (5.70 - 8.94) 1994 Modelled IHME
7.06 (5.60 - 8.73) 1993 Modelled IHME
6.97 (5.50 - 8.61) 1992 Modelled IHME
6.89 (5.41 - 8.54) 1991 Modelled IHME
6.74 (5.23 - 8.45) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
9,521 (6,625 - 13,105) 2019 Modelled IHME
9,342 (6,672 - 12,744) 2018 Modelled IHME
9,156 (6,688 - 12,090) 2017 Modelled IHME
8,969 (6,976 - 11,433) 2016 Modelled IHME
8,648 (6,723 - 10,850) 2015 Modelled IHME
8,410 (6,502 - 10,660) 2014 Modelled IHME
8,163 (6,372 - 10,273) 2013 Modelled IHME
8,004 (6,275 - 10,032) 2012 Modelled IHME
7,777 (6,084 - 9,702) 2011 Modelled IHME
7,508 (5,939 - 9,444) 2010 Modelled IHME
7,148 (5,653 - 8,872) 2009 Modelled IHME
6,920 (5,511 - 8,526) 2008 Modelled IHME
6,644 (5,258 - 8,147) 2007 Modelled IHME
6,347 (5,000 - 7,875) 2006 Modelled IHME
6,038 (4,775 - 7,523) 2005 Modelled IHME
5,834 (4,666 - 7,151) 2004 Modelled IHME
5,596 (4,452 - 6,819) 2003 Modelled IHME
5,341 (4,153 - 6,630) 2002 Modelled IHME
5,043 (3,826 - 6,388) 2001 Modelled IHME
5,051 (3,893 - 6,323) 2000 Modelled IHME
4,897 (3,778 - 6,218) 1999 Modelled IHME
4,514 (3,373 - 5,796) 1998 Modelled IHME
4,370 (3,308 - 5,557) 1997 Modelled IHME
4,554 (3,576 - 5,700) 1996 Modelled IHME
4,417 (3,497 - 5,452) 1995 Modelled IHME
4,295 (3,401 - 5,339) 1994 Modelled IHME
4,171 (3,307 - 5,154) 1993 Modelled IHME
4,072 (3,209 - 5,026) 1992 Modelled IHME
3,974 (3,118 - 4,921) 1991 Modelled IHME
3,832 (2,975 - 4,805) 1990 Modelled IHME
3,960 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
18 (12 - 23) 2019 Modelled IHME
18 (12 - 23) 2018 Modelled IHME
17 (12 - 23) 2017 Modelled IHME
17 (12 - 23) 2016 Modelled IHME
17 (12 - 23) 2015 Modelled IHME
17 (12 - 23) 2014 Modelled IHME
17 (12 - 23) 2013 Modelled IHME
17 (12 - 23) 2012 Modelled IHME
17 (12 - 23) 2011 Modelled IHME
17 (12 - 23) 2010 Modelled IHME
17 (12 - 22) 2009 Modelled IHME
17 (12 - 22) 2008 Modelled IHME
17 (12 - 22) 2007 Modelled IHME
16 (12 - 22) 2006 Modelled IHME
16 (11 - 22) 2005 Modelled IHME
16 (11 - 21) 2004 Modelled IHME
16 (11 - 21) 2003 Modelled IHME
16 (11 - 21) 2002 Modelled IHME
16 (11 - 21) 2001 Modelled IHME
16 (11 - 21) 2000 Modelled IHME
16 (11 - 21) 1999 Modelled IHME
16 (11 - 21) 1998 Modelled IHME
16 (11 - 21) 1997 Modelled IHME
16 (11 - 21) 1996 Modelled IHME
16 (11 - 21) 1995 Modelled IHME
16 (11 - 21) 1994 Modelled IHME
16 (11 - 21) 1993 Modelled IHME
16 (11 - 22) 1992 Modelled IHME
16 (11 - 22) 1991 Modelled IHME
16 (12 - 22) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
24 2017 Survey/reported Thailand Ending AIDS, 2015; Aramrattana A, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
21 2016 Survey/reported Larney et al, 2017
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
13,240
2019
(9,240 - 18,333)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
9,521
2019
(6,625 - 13,105)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
99 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
24
2017
(2 - 0)
Thailand Ending AIDS, 2015; Aramrattana A, 2017
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources